Cover Image

Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis

Objective: To delineate the curative effect and safety of anti-fibrosis Chinese patent medicines (CPMs) combined with ursodeoxycholic acid (UDCA) for primary biliary cholangitis (PBC).Methods: A literature search was conducted using PubMed, Web of Science, Embase, Cochrane Library, Wanfang database,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yufei Bi (Author), Ke Shi (Author), Jialiang Chen (Author), Xianbo Wang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
by: Guilherme Grossi Lopes Cançado, et al.
Published: (2022)

A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid
by: Chunlei Li, et al.
Published: (2022)

Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis
by: Xuan Guoyun, et al.
Published: (2022)

Use of Ursodeoxycholic Acid for the Treatment of Biliary Dysfunction in Children
by: T.V. Yaroshevskaya, et al.
Published: (2013)

Experience of using ursodeoxycholic acid in the therapy of biliary sludge in children
by: O.Yu. Belousova, et al.
Published: (2018)

New developments in the treatment of primary biliary cholangitis – role of obeticholic acid
by: Jhaveri MA, et al.
Published: (2017)

Antimitochindrial and antinuclear antibodies in primary biliary cholangitis
by: Dana Saipiyeva, et al.
Published: (2019)

Experimental Pharmacological Agents for the Treatment of Primary Biliary Cholangitis
by: Floreani A
Published: (2020)

Early cholangitis after portoenterostomy in children with biliary atresia
by: Priya Ramachandran, et al.
Published: (2019)

Quality of Life in Primary Biliary Cholangitis - Advances in the Treatment
by: Agnieszka Kuzio, et al.
Published: (2024)

Health related quality of life in patients with primary biliary cholangitis
by: Fahad Abdallah Yassin, et al.
Published: (2022)

Gastric Xanthomatosis Secondary to Lipoprotein X in Primary Biliary Cholangitis
by: Erin Petrie MD, et al.
Published: (2022)

Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis
by: Zhang Y, et al.
Published: (2015)

Characteristics of the Gut Microbiome and IL-13/TGF-β1 Mediated Fibrosis in Post-Kasai Cholangitis of Biliary Atresia
by: Lingdu Meng, et al.
Published: (2021)

Diffuse xanthomas in a patient with primary biliary cholangitis and lipoprotein X
by: Jasmine Harris, MS, et al.
Published: (2021)

Therapeutic efficacy evaluation of the reference drug ursodeoxycholic acid and its analogues in the biliary sludge dissolution: a meta-analysis
by: Yury A. Kucheryavyy, et al.
Published: (2023)

Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study
by: Hui Yang, et al.
Published: (2020)

Concurrence of multiple sclerosis and primary biliary cholangitis: A case series study
by: Mokhgan Sattar, et al.
Published: (2020)

ACUTE CHOLANGITIS, COMPLICATED BY BILIARY SEPSIS: CLINICAL CASE WITH A FAVORABLE OUTCOME
by: I. G. Malakhova, et al.
Published: (2016)

Autoimmune hepatitis and primary biliary cholangitis overlap syndrome after COVID-19
by: Marlone Cunha-Silva, et al.
Published: (2023)

STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY?
by: I. N. Grigorieva, et al.
Published: (2016)

STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY?
by: I. N. Grigorieva, et al.
Published: (2016)

STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY)
by: S. Yu. Martsevich, et al.
Published: (2015)

STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY)
by: S. Yu. Martsevich, et al.
Published: (2015)

Early bile drainage improves native liver survival in biliary atresia without cholangitis
by: Fei Liu, et al.
Published: (2023)

Evaluation of the effects of additional therapy with Berberis vulgaris oxymel in patients with refractory primary sclerosing cholangitis and primary biliary cholangitis: A quasi-experimental study
by: Zahra Naghibi, et al.
Published: (2021)

Ursodeoxycholic acid in neonatal sepsis-associated cholestasis
by: Rita Mey Rina, et al.
Published: (2014)

Endoscopic Extraction of Biliary Fascioliasis Diagnosed Using Intraductal Ultrasonography in a Patient with Acute Cholangitis
by: Ji Su Ha, et al.
Published: (2015)

Evaluation of LiangXue JieDu Therapy in Combination With Western Medicine for Acute-On-Chronic Liver Failure: A Systematic Review and meta-Analysis
by: Ke Shi, et al.
Published: (2022)

Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinoma
by: Ke Shi, et al.
Published: (2023)

Characterization of patients with primary biliary cholangitis and autoimmune hepatitis from a community hospital in East Harlem
by: Priyanka Yerragorla, et al.
Published: (2020)

Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial
by: Robyn von Maltzahn, et al.
Published: (2024)

Clinical course and response to treatment of Cuban patients with primary biliary cholangitis. Institute of Gastroenterology, 2003-2020
by: Deyanira La Rosa Hernández, et al.
Published: (2022)

Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis
by: Chenyi Xu, et al.
Published: (2022)

Attenuation of the severity and changes in the microbiota in an animal model of primary biliary cholangitis by FOXP3− regulatory T cells
by: Yi‐Lien Chen, et al.
Published: (2023)

Combination therapy of ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome: a meta-analysis
by: Zhang H, et al.
Published: (2015)

Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis
by: Urszula Wasik, et al.
Published: (2020)

Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis
by: Mona L. Martin, et al.
Published: (2019)

Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain
by: Marcello Dallio, et al.
Published: (2024)

Atypical primary biliary cholangitis results in vanishing bile duct syndrome with cutaneous xanthomas: a case report
by: Yuebo Jia, et al.
Published: (2022)